These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3052622)

  • 1. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders.
    Mannucci PM
    Blood; 1988 Nov; 72(5):1449-55. PubMed ID: 3052622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease.
    Mannucci PM; Cattaneo M
    Haemostasis; 1992; 22(5):276-80. PubMed ID: 1478539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
    Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
    Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
    Santiago-Borrero PJ; Casanova R
    Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin analogues. Their role in disorders of hemostasis.
    Mannuccio PM; Altieri D; Faioni E
    Ann N Y Acad Sci; 1987; 509():71-81. PubMed ID: 3122621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).
    Mannucci PM; Bettega D; Cattaneo M
    Br J Haematol; 1992 Sep; 82(1):87-93. PubMed ID: 1419807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.
    Sharma R; Stein D
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDAVP in acquired von Willebrand syndrome associated with multiple myeloma.
    Takahashi H; Nagayama R; Tanabe Y; Satoh K; Hanano M; Mito M; Shibata A
    Am J Hematol; 1986 Aug; 22(4):421-9. PubMed ID: 3088986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
    Lethagen S; Harris AS; Nilsson IM
    Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
    Rose EH; Aledort LM
    Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of DDAVP in children with bleeding disorders.
    Ben-Ami T; Revel-Vilk S
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S41-3. PubMed ID: 23109357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of desmopressin as a hemostatic agent: a concise review.
    Franchini M
    Am J Hematol; 2007 Aug; 82(8):731-5. PubMed ID: 17492648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Desmopressin in the treatment of hemorrhagic diathesis].
    Haar D; Hasselbalch HC
    Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.
    Svensson PJ; Bergqvist PB; Juul KV; Berntorp E
    Blood Rev; 2014 May; 28(3):95-102. PubMed ID: 24703870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of desmopressin acetate (DDAVP) to hemophiliacs.
    Dewald DL; Briggs B; Smith RE
    Thromb Res; 1980 Jun; 18(5):617-22. PubMed ID: 6774441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.